Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Cash from Operations: 2023-2024

Historic Cash from Operations for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$78.7 million.

  • CG Oncology's Cash from Operations fell 144.32% to -$38.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$116.8 million, marking a year-over-year decrease of 60.66%. This contributed to the annual value of -$78.7 million for FY2024, which is 72.32% down from last year.
  • Per CG Oncology's latest filing, its Cash from Operations stood at -$78.7 million for FY2024, which was down 72.32% from -$45.7 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Cash from Operations peaked at -$45.7 million during FY2023, and registered a low of -$78.7 million during FY2024.
  • For the 2-year period, CG Oncology's Cash from Operations averaged around -$62.2 million, with its median value being -$62.2 million (2023).
  • Data for CG Oncology's Cash from Operations shows a maximum YoY crashed of 72.32% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Cash from Operations stood at -$45.7 million in 2023, then plummeted by 72.32% to -$78.7 million in 2024.